PDF(1861 KB)
PDF(1861 KB)
PDF(1861 KB)
氟康唑预防极低出生体重儿侵袭性真菌感染疗效和安全性的Meta分析
Efficacy and safety of fluconazole in prophylaxis of invasive fungal infections in very low birth weight infants: a Meta analysis
目的 系统评价使用氟康唑预防极低出生体重儿（VLBWI）侵袭性真菌感染的疗效和安全性，为临床更好地预防性使用氟康唑提供依据。方法 计算机检索PubMed、Embase、Cochrane图书馆、万方数据库、中国科技期刊数据库（维普）和中国知网，纳入VLBWI预防性使用氟康唑的随机对照试验（RCT）研究。采用Review Manager 5.3统计软件对符合纳入标准的临床研究进行Meta分析。结果 共纳入12篇RCT研究，合计1 679例VLBWI。Meta分析结果显示：试验组（使用氟康唑）侵袭性真菌感染的发生率显著低于安慰剂对照组（RR=0.44，95% CI：0.27~0.71，P < 0.001）；真菌定植率低于对照组（RR=0.31，95% CI：0.24~0.40，P < 0.001）；住院期间病死率低于对照组（RR=0.74，95% CI：0.58~0.94，P=0.01）。使用不同预防剂量氟康唑的两组侵袭性真菌感染发生率和真菌定植率比较差异均无统计学意义（P > 0.05）；耐药情况及并发症发生率在试验组和对照组组间比较差异均无统计学意义（P > 0.05）。结论 氟康唑预防VLBWI侵袭性真菌感染有效且相对安全。小剂量给药可取得类似预防效果。
Objective To assess the efficacy and safety of fluconazole in the prophylaxis of invasive fungal infection in very low birth weight (VLBW) infants. Methods Databases including PubMed, Embase, the Cochrane Library, Wanfang Data, Weipu, and CNKI were searched for randomized controlled trials (RCTs) of prophylactic fluconazole in VLBW infants. Review Manager 5.3 software was used to perform a Meta analysis of the included studies. Results A total of 12 RCTs were included, involving 1 679 VLBW infants. The Meta analysis showed that prophylactic fluconazole significantly reduced the incidence of invasive fungal infection (RR=0.44, 95%CI:0.27-0.71, P < 0.001), the incidence of fungal colonization (RR=0.31, 95%CI:0.24-0.40, P < 0.001), and the mortality during hospitalization (RR=0.74, 95%CI:0.58-0.94, P=0.01) compared with the control group. There were no significant differences between VLBW infants using different doses of fluconazole in the incidence of invasive fungal infection and fungal colonization (P > 0.05). No significant differences were found in the incidence of fluconazole resistance and complications between the fluconazole and control groups (P > 0.05). Conclusions Prophylactic fluconazole can effectively and safely prevent invasive fungal infection in VLBW infants, even at a small dose.
氟康唑 / 侵袭性真菌感染 / Meta分析 / 极低出生体重儿
Fluconazole / Invasive fungal infection / Meta analysis / Very low birth weight infant
[1] Kaufman DA. Challenging issues in neonatal candidiasis[J]. Curr Med Res Opin, 2010, 26(7):1769-1778.
[2] Clerihew L, Lamagni TL, Brocklehurst P, et al. Invasive fungal infection in very low birthweight infants:national prospective surveillance study[J]. Arch Dis Child Fetal Neonatal Ed, 2006, 91(3):F188-F192.
[3] Boghossian NS, Page GP, Bell EF, et al. Late-onset sepsis in very low birth weight infants from singleton and multiple-gestation births[J]. J Pediatr, 2013, 162(6):1120-1124.e1.
[4] Feja KN, Wu F, Roberts K, et al. Risk factors for candidemia in critically ill infants:a matched case-control study[J]. J Pediatr, 2005, 147(2):156-161.
[5] Xia H, Wu H, Xia S, et al. Invasive Candidiasis in preterm neonates in China:a retrospective study from 11 NICUS during 2009-2011[J]. Pediatr Infect Dis J, 2014, 33(1):106-109.
[6] Benjamin DK Jr, Stoll BJ, Fanaroff AA, et al. Neonatal candidiasis among extremely low birth weight infants:risk factors, mortality rates, and neurodevelopmental outcomes at 18 to 22 months[J]. Pediatrics, 2006, 117(1):84-92.
[7] Stoll BJ, Hansen NI, Adams-Chapman I, et al. Neuro-developmental and growth impairment among extremely low-birth-weight infants with neonatal infection[J]. JAMA, 2004, 292(19):2357-2365.
[8] Cleminson J, Austin N, McGuire W. Prophylactic systemic antifungal agents to prevent mortality and morbidity in very low birth weight infants[J]. Cochrane Database Syst Rev, 2015, (10):CD003850.
[9] 张金萍, 陈超. 氟康唑预防极低出生体重儿真菌感染有效性和安全性的Meta分析[J]. 中华儿科杂志, 2009, 47(12):891-897.
[10] Leonart LP, Tonin FS, Ferreira VL, et al. Fluconazole doses used for prophylaxis of invasive fungal infection in neonatal intensive care units:a network Meta-analysis[J]. J Pediatr, 2017, 185:129-135.e6.
[11] Ericson JE, Kaufman D, Kicklighter SD, et al. Fluconazole prophylaxis for the prevention of candidiasis in premature infants:a Meta-analysis using patient-level data[J]. Clin Infect Dis, 2016, 63(5):604-610.
[12] Rios JFDS, Camargos PAM, Corrêa LP, et al. Fluconazole prophylaxis in preterm infants:a systematic review[J]. Braz J Infect Dis, 2017, 21(3):333-338.
[13] Blyth CC, Barzi F, Hale K, et al. Chemoprophylaxis of neonatal fungal infections in very low birthweight infants:efficacy and safety of fluconazole and nystatin[J]. J Paediatr Child Health, 2012, 48(9):846-851.
[14] Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials:is blinding necessary?[J]. Control Clin Trials, 1996, 17(1):1-12.
[15] Kicklighter SD, Springer SC, Cox T, et al. Fluconazole for prophylaxis against candidal rectal colonization in the very low birth weight infant[J]. Pediatrics, 2001, 107(2):293-298.
[16] Kaufman D, Boyle R, Hazen KC, et al. Fluconazole prophylaxis against fungal colonization and infection in preterm infants[J]. N Engl J Med, 2001, 345(23):1660-1666.
[17] Kaufman D, Boyle R, Hazen KC, et al. Twice weekly fluconazole prophylaxis for prevention of invasive Candida infection in high-risk infants of <1000 grams birth weight[J]. J Pediatr, 2005, 147(2):172-179.
[18] Manzoni P, Stolfi I, Pugni L, et al. A multicenter, randomized trial of prophylactic fluconazole in preterm neonates[J]. N Engl J Med, 2007, 356(24):2483-2495.
[19] Parikh TB, Nanavati RN, Patankar CV, et al. Fluconazole prophylaxis against fungal colonization and invasive fungal infection in very low birth weight infants[J]. Indian Pediatr, 2007, 44(11):830-837.
[20] 吴婕翎, 李文成, 杨杰. 氟康唑预防极低出生体重儿真菌感染[J]. 中国新生儿科杂志, 2009, 24(2):82-84.
[21] Aydemir C, Oguz SS, Dizdar EA, et al. Randomised controlled trial of prophylactic fluconazole versus nystatin for the prevention of fungal colonisation and invasive fungal infection in very low birth weight infants[J]. Arch Dis Child Fetal Neonatal Ed, 2011, 96(3):F164-F168.
[22] Kaufman DA, Cuff AL, Wamstad JB, et al. Fluconazole prophylaxis in extremely low birth weight infants and neurodevelopmental outcomes and quality of life at 8 to 10 years of age[J]. J Pediatr, 2011, 158(5):759-765.e1.
[23] Benjamin DK Jr, Hudak ML, Duara S, et al. Effect of fluconazole prophylaxis on candidiasis and mortality in premature infants:a randomized clinical trial[J]. JAMA, 2014, 311(17):1742-1749.
[24] Jannatdoust A, Imani V. The effect of prophylactic intravenous fluconazole on the clinical outcome of preterm infants during hospitalization[J]. Int J Women's Health Reprod Sci, 2015, 3(4):212-216.
[25] Kirpal H, Gathwala G, Chaudhary U, et al. Prophylactic fluconazole in very low birth weight infants admitted to neonatal intensive care unit:randomized controlled trial[J]. J Matern Fetal Neonatal Med, 2016, 29(4):624-628.
[26] 康莺歌, 常晶, 姚爱梅. 氟康唑预防极低出生体重儿侵袭性真菌感染的临床观察[J]. 医药论坛杂志, 2017, 38(2):31-33.
[27] Brion LP, Uko SE, Goldman DL. Risk of resistance associated with fluconazole prophylaxis:systematic review[J]. J Infect, 2007, 54(6):521-529.
[28] Sarvikivi E, Lyytikäinen O, Soll DR, et al. Emergence of fluconazole resistance in a Candida parapsilosis strain that caused infections in a neonatal intensive care unit[J]. J Clin Microbiol, 2005, 43(6):2729-2735.
[29] Yoder BA, Sutton DA, Winter V, et al. Resistant Candida parapsilosis associated with long term fluconazole prophylaxis in an animal model[J]. Pediatr Infect Dis J, 2004, 23(7):687-688.
